[go: up one dir, main page]

BR9909476A - Novos tratamentos para distúrbios nervosos - Google Patents

Novos tratamentos para distúrbios nervosos

Info

Publication number
BR9909476A
BR9909476A BR9909476-2A BR9909476A BR9909476A BR 9909476 A BR9909476 A BR 9909476A BR 9909476 A BR9909476 A BR 9909476A BR 9909476 A BR9909476 A BR 9909476A
Authority
BR
Brazil
Prior art keywords
new treatments
nervous disorders
disease
reboxetine
ocd
Prior art date
Application number
BR9909476-2A
Other languages
English (en)
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Philip F Von Voigtlander
Erik Ho Fong Wong
Original Assignee
Pharmacia & Upjohn Spa
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa, Upjohn Co filed Critical Pharmacia & Upjohn Spa
Publication of BR9909476A publication Critical patent/BR9909476A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

<B>NOVOS TRATAMENTOS PARA DISTúRBIOS NERVOSOS<D> Esta aplicação de patente descreve o tratamento de Doença compulsiva Obsessiva (OCD), e Doença do Pânico (PD), compreendendo a administração de uma dose não tóxica, terapeuticamente eficaz de Reboxetine e derivados e ou sais farmaceuticamente aceitáveis deste a um paciente.
BR9909476-2A 1998-04-13 1999-04-02 Novos tratamentos para distúrbios nervosos BR9909476A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (1)

Publication Number Publication Date
BR9909476A true BR9909476A (pt) 2000-12-19

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909476-2A BR9909476A (pt) 1998-04-13 1999-04-02 Novos tratamentos para distúrbios nervosos

Country Status (25)

Country Link
US (1) US6391876B1 (pt)
EP (1) EP1071418B1 (pt)
JP (1) JP2002511408A (pt)
KR (1) KR100555279B1 (pt)
CN (1) CN1197569C (pt)
AT (1) ATE277617T1 (pt)
AU (1) AU755612B2 (pt)
BR (1) BR9909476A (pt)
CA (1) CA2320722A1 (pt)
DE (1) DE69920679T2 (pt)
DK (1) DK1071418T3 (pt)
EA (1) EA003546B1 (pt)
ES (1) ES2228035T3 (pt)
HU (1) HUP0101748A3 (pt)
IL (1) IL138887A0 (pt)
IT (1) IT1305322B1 (pt)
NO (1) NO20005131D0 (pt)
NZ (1) NZ507693A (pt)
PL (1) PL194039B1 (pt)
PT (1) PT1071418E (pt)
SI (1) SI1071418T1 (pt)
SK (1) SK14482000A3 (pt)
TR (1) TR200002970T2 (pt)
WO (1) WO1999052518A2 (pt)
ZA (1) ZA200004480B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
EP1632235A3 (en) * 1999-07-01 2006-06-14 Pharmacia & Upjohn Company LLC Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
WO2001001973A2 (en) 1999-07-01 2001-01-11 Pharmacia & Upjohn Company Highly selective norepinephrine reuptake inhibitors and methods of using the same
CA2426069A1 (en) * 2000-11-15 2002-05-23 David Michelson Treatment of anxiety disorders
RU2286341C2 (ru) * 2002-06-17 2006-10-27 Фармация Италия С.П.А. Фармацевтические соли ребоксетина
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
CA2306233A1 (en) 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals

Also Published As

Publication number Publication date
CA2320722A1 (en) 1999-10-21
HUP0101748A2 (hu) 2001-11-28
HUP0101748A3 (en) 2001-12-28
IT1305322B1 (it) 2001-05-04
EP1071418B1 (en) 2004-09-29
PT1071418E (pt) 2004-12-31
ITMI980870A1 (it) 1999-10-23
AU755612B2 (en) 2002-12-19
US6391876B1 (en) 2002-05-21
EA200001058A1 (ru) 2001-04-23
PL346294A1 (en) 2002-01-28
JP2002511408A (ja) 2002-04-16
SI1071418T1 (en) 2005-04-30
DE69920679D1 (de) 2004-11-04
TR200002970T2 (tr) 2001-01-22
NZ507693A (en) 2003-08-29
DE69920679T2 (de) 2006-03-02
SK14482000A3 (sk) 2001-08-06
EP1071418A2 (en) 2001-01-31
DK1071418T3 (da) 2005-01-03
NO20005131L (no) 2000-10-12
CN1197569C (zh) 2005-04-20
ES2228035T3 (es) 2005-04-01
WO1999052518A3 (en) 1999-12-02
AU3635199A (en) 1999-11-01
KR100555279B1 (ko) 2006-03-03
PL194039B1 (pl) 2007-04-30
ATE277617T1 (de) 2004-10-15
EA003546B1 (ru) 2003-06-26
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24
CN1293569A (zh) 2001-05-02
IL138887A0 (en) 2001-11-25
NO20005131D0 (no) 2000-10-12
WO1999052518A2 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
EA200701175A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
EP1558220A4 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
WO2002053140A3 (en) New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
BRPI0414347A (pt) associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade
PT1276476E (pt) Utilizacao de substancias bradicardicas no tratamento de doencas do miocardio associadas a hipertrofia e novas combinacoes de medicamentos
BR0313411A (pt) Uso de reboxetina para o tratamento de ondas de calor
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
BR9909476A (pt) Novos tratamentos para distúrbios nervosos
PT1069900E (pt) Novos tratamentos para disturbios nervosos
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
TW200420290A (en) Methods for the treatment, prevention and management of macular degeneration
BR9909917A (pt) Novos usos e combinações de cabergoline e pramipexole
BR0010961A (pt) Composto, composição farmacêutica, e, métodos para tratar epilepsia, ataques de tontura, hipocinésia, e distúrbios cranianos, distúrbios neurodegenerativos, depressão, ansiedade, pânico, dor, distúrbios neuropatológicos e distúrbios do sono
BR0316451A (pt) Combinação sinergìstica compreendendo roflumilast e formoterol
WO2005046594A3 (en) Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders
BR0009704A (pt) Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
BR0115881A (pt) Emprego de compostos ciclohexanona substituìdos de 6-dimetilaminometil-1-fenil para a terapia da incontinência urinária

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/5375, A61P 25/22

Ipc: A61K 31/5375 (2007.10), A61P 25/22 (2007.10)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.